New Software Tool Boosts Odds of Finding Lung Cancer

Researchers said that a new software tool may help doctors eliminate mistakes when judging whether a spot that turns up on a smoker's lung scan is cancerous or not.

The clinical risk assessment method described in the New England Journal of Medicine helped correctly decide nine times out of 10 whether a spot or lesion was benign or malignant.

Lung Cancer Risk Reduced by Half by Eating Raw Garlic Twice a Week
A recent study published online in Cancer Prevention Research has revealed that the risk of lung cancer can reduced by half with consuming raw garlic twice a week.

Computed tomography (CT) scans can save lives, but they are imperfect and can also lead to unnecessary surgery as much as 25 percent of the time, research has shown.

"Now, we have evidence that our model and risk calculator can accurately predict which abnormalities that show up on a first CT require further follow up, such as a repeat CT scan, a biopsy, or surgery, and which ones do not," said co-principal investigator Stephen Lam.

"This is extremely good news for everyone -- from the people who are high risk for developing lung cancer to the radiologists, respirologists and thoracic surgeons who detect and treat it," said Lam, a professor of medicine at the University of British Columbia.

New Drug Target for Untreatable Form of Lung Cancer Identified
Chemical signals sent out by collagen appear to protect against cancer's growth, say researchers.

The prediction model includes a risk calculator that assesses age, sex, family history, emphysema, location of the nodule and other characteristics.

"Reducing the number of needless tests and increasing rapid, intensive diagnostic workups in individuals with high-risk nodules are major goals of the model," said Martin Tammemagi, an epidemiologist at Brock University who developed it.

Pattern in Lung Cancer Pathology may Predict Cancer Recurrence After Surgery: Study
A specific pattern found in the tumor pathology of some lung cancer patients is a strong predictor of recurrence, finds a new study.

Researchers tested the tool in a population of nearly 3,000 people, including current and former smokers aged 50 to 75 who had undergone low-dose CT screening.

Researchers found that bigger nodules did not always mean cancer, and that cancers were more often found in the upper parts of the lung than the lower lobes.

RNA Diagnostic Test from Paraffin Improves Lung Cancer Diagnosis
In the era of personalized medicine, knowing what type of lung cancer a patient has is critical to determine which drug will work best and which therapies are safest.

The risk analysis model helped correctly determine whether the nodule was cancerous or not 94 percent of the time, which the researchers described as "excellent predictive accuracy."

Furthermore, it helped diagnose tricky small nodules that are at most 10 millimeters in size 90 percent of the time.

"Previous prediction models for lung nodules were hospital-based or clinic-based and showed a high prevalence of lung cancer -- 23 to 75 percent, as compared with 5.5 percent in our study," said the article.

"Our models are coupled with risk calculators, which make possible the rapid and easy calculation of lung-cancer risk given the characteristics of the person and the nodules."

The approach could save money and cut down on false positives, said Christine Berg, co-principal investigator of the National Lung Screening Trial, describing it as "a major advance for clinicians performing lung cancer screening."

"Coupled with continued public health efforts to lower cigarette smoking, this work will have international impact on the leading cause of cancer death worldwide."

Source-AFP